Related by context. All words. (Click for frequent words.) 81 small molecule chemotherapeutic 77 FOLOTYN ® 76 molecular imaging radiopharmaceutical 75 Zemiva ™ 75 targeted radiotherapeutic 75 mertansine 75 SinuNase TM 75 Solazed TM 75 investigational humanized monoclonal antibody 75 PI3K/Akt pathway inhibitor 74 refractory chronic lymphocytic 74 candidate AQ4N 74 Anturol ® 74 2 methoxyestradiol 74 Phase #b/#a clinical 74 BiovaxID TM 74 Panzem R 74 Xcytrin R 74 Personalized Immunotherapy 74 lexidronam injection 73 XL# XL# 73 Panzem R NCD 73 PNP inhibitor 73 MAGE A3 ASCI 73 topically applied SEPA 73 hypoxia activated prodrug 73 Zemiva TM 73 huC# DM4 73 trastuzumab DM1 T DM1 73 delivers fluocinolone acetonide FA 73 Panzem NCD 73 mitogen activated ERK kinase 73 SinuNase ™ 73 IMiDs R 73 Cloretazine ® 73 oral prodrug 72 overactive bladder AA# 72 Aflibercept 72 TLK# 72 IL# PE#QQR 72 PANVAC VF 72 ALTROPANE R 72 R sorafenib tablets 72 PROSTASCINT R 72 SPRYCEL ® 72 Azedra ™ 72 XL# XL# XL# 72 Solazed ™ 72 Iluvien ® 72 methylnaltrexone bromide 72 Initiate Clinical Trial 72 phase IIb clinical 72 Alfacell proprietary ribonuclease 72 non nucleoside inhibitor 72 sorafenib tablets 72 dasatinib Sprycel ® 72 PrevOnco 72 polysaccharide polymer 72 Luteinizing Hormone Releasing Hormone 72 Augment TM 72 orally administered inhibitor 72 IgG1 monoclonal antibody 72 include PLX IBD 72 novel histone deacetylase 72 alvespimycin 72 Cloretazine R 72 acetonide FA 71 Oracea TM 71 Pivotal Phase III 71 sapacitabine CYC# 71 INSPIRE Trial Phase III 71 candidate deforolimus 71 IMiDs ® compound 71 acyclovir Lauriad R 71 Anturol TM 71 LE SN# 71 MKC# MT 71 liposomal formulation 71 antibody MAb 71 vapreotide acetate 71 virus HCV protease inhibitor 71 Oral NKTR 71 oxybutynin ATD TM 71 multicenter Phase II 71 XL# anticancer compounds 71 Initiates Enrollment 71 telomerase inhibitor drug 71 targeting Inflammatory Bowel 71 include Phenoptin TM 71 hyaluronidase enzyme 71 ongoing Phase 1b 71 Trofex ™ 71 Zenvia ™ 71 systemic anaplastic large 71 Kuvan TM sapropterin 71 Hedgehog Pathway Inhibitor 71 Onalta ™ 71 HepeX B TM 71 investigational pan BCR 71 forodesine 71 cetuximab Erbitux R 71 Cloretazine 71 Tezampanel 71 Completes Patient Enrollment 71 PROVENGE ® 71 hypoxia selective 71 LibiGel ® 71 Initiates Phase II 71 Carfilzomib 71 Genasense ® 71 Auxilium transmucosal film 71 RH1 targeted chemotherapeutic agent 71 Clolar ® 71 CRMD# 70 CB2 selective receptor agonist 70 JAK inhibitor 70 pralatrexate injection folate analogue 70 lintuzumab SGN 70 histone deacetylase HDAC inhibitor 70 MKC# MKC# PP 70 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 70 VISICOL R 70 Entereg R 70 targets Galectin receptors 70 docetaxel Taxotere R 70 Pegloticase 70 Phase IIb clinical trials 70 investigational pharmacologically unique 70 Phase Ib II 70 KRYSTEXXA TM pegloticase 70 PHX# 70 ocular formulation 70 pan histone deacetylase 70 Hsp# Inhibitor 70 Immunotherapeutic 70 arsenic trioxide injection 70 pan HDAC inhibitor 70 Genasense ® oblimersen 70 Generx TM 70 Inhalation Solution 70 Phase Ib study 70 Squalamine 70 erlotinib Tarceva ® 70 Zorbtive TM 70 Generx ™ 70 FavId 70 Aganocide 70 dependent kinase inhibitor 70 Iluvien TM 70 targeted antifolate 70 GVAX ® 70 reslizumab 70 interferon gamma 1b 70 GW# [003] 70 COLAZAL R 70 Omacetaxine 70 phase IIa clinical 70 dextromethorphan quinidine 70 samarium Sm 70 anticancer compound 70 Qutenza TM 70 oral proteasome inhibitor 70 Polymer Microspheres 70 ALN HPN 70 proprietary HuCNS SC 70 muscarinic receptor agonist 70 investigational antiplatelet agent 70 investigational immunotherapy 70 ThermoDox ® clinical 70 Cannabinor 70 integrin inhibitor 70 advanced metastatic renal 70 TOCOSOL Camptothecin 70 oral ridaforolimus 70 Azedra TM Onalta TM 70 IMPDH inhibitor 70 fosbretabulin 70 PDE4 inhibitor 70 EGFr expressing metastatic colorectal 70 LEVADEX TM 70 thalidomide Thalomid 70 Presents Preclinical Data 70 Factor VIIa 70 LEP ETU 70 Tesetaxel 70 R lenalidomide 70 HGS ETR2 70 histamine dihydrochloride 69 ALN PCS 69 AzaSite Plus 69 CEQ# 69 ILUVIEN ® 69 pharmacokinetic PK study 69 TRISENOX ® 69 SPL# Gel vaginal microbicide 69 LEUKINE 69 Disease IBD 69 personalized cellular immunotherapy 69 AAG geldanamycin analog 69 markets HP Acthar 69 dacetuzumab SGN 69 intravenous acetaminophen 69 IMA# 69 OAB overactive bladder 69 oral picoplatin 69 R Saizen R 69 topical gel formulation 69 YONDELIS 69 Amrubicin 69 selective kinase inhibitor 69 IV Busulfex 69 AzaSite Xtra 69 tubulin inhibitor 69 Perflubutane Polymer Microspheres 69 TRO# 69 Silodosin 69 intranasal formulation 69 modified glutathione analog 69 JZP 69 CYT# potent vascular disrupting 69 essential thrombocythemia ET 69 Xanafide 69 novel immunomodulatory 69 R roscovitine CDK cyclin 69 Cintredekin Besudotox 69 Tarceva TM 69 Triapine 69 CTAP# Injection 69 AEG# 69 candidate REP# 69 Cleviprex TM clevidipine 69 Daclizumab 69 vinca alkaloid 69 Serostim ® 69 Telik logo TELINTRA 69 GEM OS2 69 kidney urologic 69 JAK1 69 sapropterin dihydrochloride Phase 69 Phase 2a clinical 69 Injectable Suspension 69 Azedra TM 69 LymphoStat B TM 69 radiation sensitizer 69 neratinib 69 Vascular Wrap TM 69 UPLYSO 69 phase III isavuconazole 69 GATTEX ® 69 cell lymphoma CTCL 69 ABL inhibitor 69 sorafenib Nexavar 69 PEGylated Fab fragment 69 investigational hepatitis C 69 Sudhir Agrawal D.Phil 69 miconazole Lauriad R 69 IMiD 69 lorvotuzumab mertansine 69 diarrhea predominant irritable 69 seliciclib CYC# 69 treat refractory angina 69 novel emulsion formulation 69 generation Hsp# inhibitor 69 BUPHENYL R 69 cutaneous T 69 ZEVALIN ® 69 oral Janus kinase 69 romidepsin novel 69 telomerase therapeutic 69 CYC# 69 Successfully Completes Phase 69 CA9 SCAN 69 humanized anti 69 RH1 69 Alocrest 69 TELINTRA 69 Quinamed 69 Diabetic Macular Edema DME 69 Xeloda ® 69 Troxatyl 69 Pyridorin 69 dasatinib Sprycel 69 evaluating Xcytrin 69 evaluating tivozanib 69 Crofelemer budesonide foam 69 refractory gout 69 proteasome inhibitor 69 Zemiva TM Trofex TM 69 candidate MyVax 69 ELACYT 69 treat chronic sinusitis 69 including eniluracil ADH 69 Liprotamase 69 FUSILEV ® 69 ™ pralatrexate injection 69 Aplidin R 69 personalized dendritic 69 QUADRAMET R 69 PLK1 SNALP 69 lucinactant 69 Nexavar ® 68 receptor tyrosine kinase inhibitor 68 selective androgen receptor modulator 68 Vascular Disrupting Agent 68 evaluating picoplatin 68 isoform selective 68 oncolytic virus therapies 68 metastatic GIST 68 rALLy clinical trial 68 Phase III Pivotal 68 OvaRex R 68 novel oral anticoagulant 68 BRIM2 68 KRN# 68 Initiated Phase 68 Traficet EN 68 Archexin 68 Luveris R Ovidrel R 68 catheter occlusion 68 adenosine injection 68 GLP1 INT TM 68 Novel Oral 68 Curaxin CBLC# 68 PEG SN# 68 HuMax TAC 68 Phase Ib clinical trials 68 HQK 68 PORxin TM 68 MyVax R 68 Serostim R 68 selective modulator 68 unique alkylating agent 68 Soliris eculizumab 68 Rebif ® 68 Romidepsin 68 Aryplase 68 selective immunoproteasome inhibitor 68 XYOTAX TM 68 lead molecular radiotherapeutic 68 GERD migraine headaches 68 MOVIPREP R 68 TRANSDUR ® 68 Anidulafungin 68 alemtuzumab MS 68 Veronate R 68 sodium thiosulfate STS 68 Elagolix 68 acetylgalactosamine 6 68 Glufosfamide 68 BLP# Liposome Vaccine 68 Proxinium TM 68 Phase 2b Clinical Trial 68 highly purified pasteurized 68 TPI ASM8 68 herpetic keratitis 68 immunotherapeutic agent 68 oxybutynin ATD ™ 68 CD# CEA 68 Androxal TM 68 sodium glucose cotransporter 68 telaprevir VX 68 candidate CRLX# 68 THR beta agonist 68 sunitinib malate 68 VEGFR2 inhibitor 68 ALVESCO ® 68 R roscovitine 68 HGS ETR1 68 investigational monoclonal antibody 68 IAP inhibitor 68 peripherally acting 68 Romiplostim 68 Ambrisentan 68 highly selective inhibitor 68 generation purine nucleoside 68 sapropterin dihydrochloride 68 Initiates Clinical Trial 68 Annamycin 68 Chemophase 68 BENLYSTA ® 68 orally inhaled 68 Cinryze TM C1 inhibitor 68 HCD# [002] 68 pralatrexate 68 ENMD # 68 plus DOXIL 68 topoisomerase II inhibitor 68 Combination REOLYSIN R 68 phenylalanine ammonia lyase 68 candidates Azedra TM 68 S1P antibody 68 ferumoxytol Injection 68 evaluating satraplatin 68 Ecallantide 68 Locteron ® 68 Excellagen 68 mGluR5 negative 68 candidate XP# 68 PROVENGE sipuleucel T 68 docetaxel Taxotere ® 68 PTH analogue 68 include GALNS N 68 Files IND 68 XOPENEX R 68 vascular disrupting agents 68 somatostatin analogue 68 Fx #A 68 potent topoisomerase II 68 Intravenous Human 68 vaginally administered lidocaine 68 IMiDs ® 68 GATTEX TM 68 oral anti arrhythmic 68 Receives Orphan Drug Designation 68 vinorelbine tartrate 68 Aurora Kinase 68 ELADUR TM 68 Dalbavancin 68 bevacizumab Avastin ® 68 OncoVEX GM CSF 68 Phase IIb Trial 68 FACTIVE R gemifloxacin 68 Initiates Clinical 68 Trodusquemine MSI 68 cancer neuroendocrine tumor 68 Trofex 68 topical non steroidal 68 tiapamil 68 class anticancer quinolone 68 relapsed multiple myeloma 68 toenail onychomycosis 68 motexafin gadolinium Injection 68 Ceflatonin R 68 TRANSDUR ™ 68 Triapine R 68 PSN# [001] 68 TÎ ² 4 68 FOLFOX6 chemotherapy regimen 68 REG1 Anticoagulation System 68 TELINTRA R 68 bevacizumab Avastin R 68 Files Investigational 68 immunosuppressive compound 68 Meets Primary Endpoint 68 Therapeutic Competitors companiesandmarkets.com adEgemonye 68 CDK cyclin dependent 68 Exherin TM 68 Hematide ™ 68 Neulasta R 68 RhuDex ® 67 refractory Hodgkin lymphoma 67 Proellex TM 67 DAVANAT 67 non porcine pancreatic 67 CTAP# Capsules 67 Xyfid TM 67 Pivotal Trial 67 TBC# 67 Achieves Primary Endpoint 67 thymalfasin 67 Allovectin 7 R 67 Exherin 67 Campath ® 67 AQ4N 67 NUEDEXTA ™ 67 small molecule Hedgehog 67 Neo Urinary Conduit 67 ionotropic glutamate receptor antagonists 67 ® bortezomib 67 3 registrational trial 67 Begins Dosing 67 LEVADEX ™ 67 Vidaza azacitidine 67 PrevOnco ™ 67 postoperative ileus POI 67 nilotinib Tasigna ® 67 BCG refractory carcinoma 67 hormone LHRH antagonist 67 Myocet 67 dextofisopam 67 Phase III Clinical Trial 67 topical antifungal 67 multicenter Phase III 67 Dendreon investigational 67 Cloretazine R VNP#M 67 ZOLINZA 67 Bezielle 67 histone deacetylase inhibitor 67 PKC# 67 monoclonal antibody conjugated 67 beta 1a 67 Dacogen injection 67 selective estrogen receptor modulator 67 candidate AP# 67 sNDAs 67 Elotuzumab 67 CR# vcMMAE 67 Phase 1b clinical trials 67 preclinical pharmacology 67 octreotide acetate 67 TELCYTA 67 Metastatic Melanoma 67 Allovectin 7 r 67 candidate iSONEP TM 67 MTP inhibitor 67 VitiGam 67 ThermoDox R 67 CYP#A# CYP#D# 67 SAR# [004] 67 corticotropin injection 67 Therapeutic Competitors 67 initiated Phase Ib 67 Dual Opioid 67 adecatumumab MT# 67 Resurgex Plus 67 human C1 inhibitor 67 Wafer polifeprosan 67 HGS ETR1 mapatumumab 67 Therapeutic Competitors Companies 67 XP# XP# 67 5 FU leucovorin 67 CINTREDEKIN BESUDOTOX 67 radiotherapeutic 67 clinical trials dacetuzumab SGN 67 NP2 Enkephalin 67 CD# monoclonal antibody 67 PXD# 67 sodium Injection 67 diagnostic radiopharmaceutical 67 Aganocide ® 67 BAY #-# 67 oral isotype selective HDAC 67 Medidur TM FA 67 JAK2 Inhibitor 67 Randomized Double blind 67 tizanidine hydrochloride short 67 TRIOLEX HE# APOPTONE HE# 67 Epratuzumab 67 rHuPH# recombinant human 67 QuadraSphere 67 Ozarelix 67 Alzhemed TM 67 Medidur ™ FA 67 ACAPODENE TM 67 Ganite ® 67 KSP inhibitor 67 brand ciclesonide HFA 67 candidate ridaforolimus 67 Inhalation Aerosol 67 Gel repository corticotropin injection 67 metaglidasen 67 Gemzar ® 67 individualized cellular immunotherapy 67 Vidaza R 67 humanised monoclonal antibody 67 depsipeptide 67 severe gastroparesis 67 EXPAREL ™ 67 Aplidin 67 itraconazole Sporanox 67 5 HT3 antagonist 67 Genasense R oblimersen 67 HCl Tablets 67 Albuferon TM 67 cromolyn sodium 67 TO AVOID PREGNANCY WHILE 67 Ceplene TM 67 Receives Orphan Drug 67 MGd 67 EcoNail 67 RELOVAIR ™ 67 Pivotal Phase 67 Vicinium TM 67 metastatic malignant 67 Trofex TM 67 mTOR mammalian target 67 diaper dermatitis complicated 67 Neutrolin 67 BRILINTA 67 Kamada AAT 67 sunitinib Sutent ® 67 R bendamustine hydrochloride 67 relapsed refractory multiple myeloma 67 recurrent metastatic ovarian cancer 67 INS# [001] 67 HDAC Inhibitor 67 Pyridorin TM 67 ALN TTR 67 refractory multiple myeloma 67 ADP receptor antagonist 67 Initiate Phase 67 ANYARA 67 Exelixis compounds 67 Navelbine R 67 Oral Fingolimod 67 Chemokine Therapeutics 67 Ovitrelle R Serostim 67 Xcellerated T Cells 67 intravesical infusion therapy 67 Randomized Phase 67 PRN FDA Approves 67 5 fluorouracil leucovorin 67 PEG PAL PEGylated recombinant 67 ALTROPANE 67 hoFH 67 sulodexide 67 Cardium Therapeutics TM 67 Initiates Phase III 67 bucindolol hydrochloride 67 Cytogen marketed 67 mapatumumab 67 drug pipeline TAFA# 67 ELND-#/AZD-# 67 novel antifolate currently 67 Soriatane R 67 Zybrestat 67 Soliris TM eculizumab 67 selective adenosine 67 DURIN TM 67 TKB# 67 interferon beta 1a infertility 67 novel anticancer 67 CD3 monoclonal antibody 67 XL# XL# XL# XL# 67 EcoNail TM 67 EXPAREL TM 67 rusalatide acetate 67 ATRA IV 67 phase IIb trial 67 Kinase Inhibitor 67 ARRY # 67 Fludara ® 67 Recombinant Human 67 Leukine ® 67 Advanced Renal Cell 67 Ophena 67 Fibrillex TM 67 accumulate preferentially 67 Onalta 67 ZYBRESTAT TM 67 fluoropyrimidine 67 leading oral taxane 67 CTAP# 67 neuropathic pain metabolic diseases 67 TRIOLEX ™ 67 Phase Ib IIa 67 BiTE R 67 IAP inhibitors 67 Cloretazine VNP#M 67 chemotherapy induced neutropenia 67 Serdaxin ® 67 Cotara ® 67 P#X# antagonist 66 multi kinase inhibitor 66 chimeric monoclonal antibody 66 trastuzumab Herceptin R 66 proprietary polysaccharide 66 MT# MEDI 66 Atiprimod 66 Cinryze ™ 66 Cetrorelix 66 Matrix Phase 2b 66 ORE# 66 inhaled AAT 66 MOZOBIL 66 novel L DOS# 66 Enzastaurin 66 prokinetic agent 66 Pralatrexate 66 MEK Inhibitor 66 pain palliation 66 EOquin TM 66 Anturol 66 NASDAQ CYTK announced 66 GLASSIA 66 Aztreonam lysine 66 oral talactoferrin 66 Saizen ® 66 NEBIDO R 66 IRX 2 66 EVIZON TM squalamine lactate 66 cetuximab Erbitux ® 66 ADVANCE PD 66 Granted Orphan Drug 66 triciribine phosphate monohydrate 66 lexidronam injection PROSTASCINT 66 Tarvacin TM 66 potent antiproliferative 66 dihydrochloride Phase 3 66 Empatic TM 66 Talabostat 66 Empatic ™ 66 Gliadel R 66 Acetavance TM intravenous acetaminophen 66 tolevamer 66 Eculizumab 66 balsalazide tablet 66 palifosfamide Zymafos TM 66 thrombin component 66 midstage clinical 66 ganetespib 66 NU# direct 66 darinaparsin ZIO 66 Seliciclib 66 anti botulism antibody 66 Corlux 66 mocetinostat MGCD# 66 markets COLAZAL 66 AMMONUL R 66 ATPace TM 66 Budesonide MMX 66 galiximab 66 NeuroSTAT ® 66 phase Ib 66 VNP#M 66 Lubiprostone 66 Tyrima 66 Pathway Inhibitor 66 Zenvia Phase III 66 topical anti infective 66 autologous cellular immunotherapy 66 candidates Azedra 66 Targretin capsules 66 PSN# [002] 66 novel VDA molecule 66 Altropane 66 Saizen R 66 SCH # 66 EP #R 66 ospemifene 66 IMPACS R 66 Copegus ® 66 Darinaparsin 66 peptidic compound 66 compound perifosine 66 PEGylated interferon beta 1a 66 RenaZorb TM 66 PEGylated anti 66 Peginterferon alfa 2b 66 proprietary intranasal insulin 66 OMS# 66 Seliciclib CYC# 66 vaccines oncolytic virus 66 STEDESA 66 Therapeutic Vaccine 66 aripiprazole Abilify 66 Gonal f R 66 phase IIb III 66 T Pred 66 Veronate 66 perifosine KRX 66 Civacir 66 rNAPc2 66 gefitinib Iressa 66 OTCBB CVBT 66 Receives Approvable Letter 66 etanercept Enbrel 66 Surgical Hemostat 66 elotuzumab 66 rasagiline tablets 66 Submits NDA 66 Phase 2a Clinical Trial 66 severe hypercholesterolemia 66 liposome injection 66 faropenem medoxomil 66 induced macular edema 66 PF # [002] 66 oral antiviral 66 HEPLISAV TM 66 TLR9 agonist 66 Pafuramidine 66 dihydrochloride 66 Phase 2b Study 66 Phenoptin 66 Orally administered 66 pseudobulbar affect PBA 66 IMPACT DCM 66 VivaGel ™ 66 refractory cutaneous T 66 personalized immunotherapy 66 PRT# 66 Azedra 66 Phase 1a clinical 66 Insegia 66 VALSTAR 66 PRTX 66 non nucleoside HCV 66 alkylating agent 66 Augment ™ 66 Staphylococcus aureus Immune Globulin 66 Kuvan sapropterin dihydrochloride 66 Polyphenon ® E 66 visilizumab 66 transthyretin mediated amyloidosis ATTR 66 6R BH4 66 Nanobody 66 adenosine A2A 66 Vidaza ® 66 orally bioavailable 66 CCX# B 66 #/#/# Cytokinetics Incorporated 66 velafermin 66 phase Ib clinical 66 randomized controlled Phase 66 novel synthetic peptide 66 LymphoStat B belimumab 66 Reports Preclinical Data 66 tartrate Inhalation Solution 66 R MSCRAMM 66 keloid scarring 66 ZK EPO 66 JOULFERON 66 Vitaxin 66 HepaGam B TM 66 Ophena TM 66 Hedgehog pathway inhibitor 66 Phase IIb Clinical Trial 66 orBec ® oral beclomethasone 66 ProLindac TM 66 HuMax EGFr 66 please visit www.advaxis.com 66 Teysuno 66 Perifosine 66 orally inhaled migraine 66 Dapagliflozin 66 ABRAXANE ® 66 Sapacitabine 66 NASDAQ OPTR 66 CYT# vascular disrupting 66 ATL# [002] 66 TRACON Pharmaceuticals 66 Nucleic Acid Detection Immunoassay 66 Ceflatonin ® 66 selective A2A adenosine receptor 66 brivanib 66 modulator SERM 66 Cethrin R 66 Nipent R 66 TransVax TM 66 Dose Ranging Study 66 drug conjugate 66 Kosan dependence 66 therefore therapeutically equivalent 66 REG2 66 trial evaluating PRX# 66 TNF Tumor Necrosis Factor 66 miconazole Lauriad 66 oral nucleoside analogue 66 Navelbine ® 66 Augment Injectable 66 #I TM# 66 Fibrin Patch 66 Eraxis 66 efaproxiral 66 Solazed 66 Palifosfamide 66 GMX# 66 HCV protease inhibitor 66 Oxycyte ® 66 TransVax tm 66 Methylnaltrexone 66 Phase Ib clinical 66 polycythemia vera PV 66 candidate TNFerade biologic 66 substantially excreted 66 Tarmogen 66 uricase 66 MGN# 66 SYCREST 66 systemically administered 66 Antigenics QS 66 irreversible inhibitor 66 oral beclomethasone dipropionate 66 candidate Gencaro TM 66 myelofibrosis polycythemia vera 66 Phase 2b clinical 66 product candidate Lpathomab 66 NV1FGF 66 ALN TTR# 66 Microplasmin 66 platform HDL Mimetic 66 EGFR HER2 66 cisplatin gemcitabine 66 Lymphoseek ® 66 Levoleucovorin 66 candidate NGX 66 factor VIIa 66 RECOTHROM R 66 Nasdaq OPTR 66 subsidiaries visit http:/www.apricusbio.com 66 orBec R oral beclomethasone 66 candidates Augment ™ 66 compound PMX # 66 incyclinide 66 Stedivaze 66 oral dual endothelin 66 DUROS 66 CCR5 antagonist 66 Angiocept 66 NasdaqGM SPPI 66 apoptosis inducer 66 evaluating Actimmune 66 allogeneic cell 66 Elvitegravir 66 NDA Submission 66 metastatic neuroendocrine tumors 66 evaluating bafetinib 66 novel topoisomerase 66 biomodulator 66 E2F Decoy 66 Tanespimycin 66 Augment ™ Bone Graft 66 marketed pegylated interferons 66 MetroGel 66 Phase IIIb clinical 66 NPC 1C 66 Diabetic Macular Edema 66 Asentar TM 66 rxRNA 66 Presents Positive 66 tramiprosate Alzhemed TM 65 product platforms AZX# 65 valopicitabine NM# 65 Bazedoxifene 65 systemic RNAi therapeutic 65 Pivotal Study 65 EGS# 65 castrate resistant prostate cancer 65 fallopian tube cancers 65 Dementia Related Psychosis 65 MEK inhibitor RDEA# 65 Allovectin 7 65 Copegus ribavirin 65 RGB # 65 Actimmune ® 65 Kuvan R 65 DOS# 65 Friedreich Ataxia FRDA 65 IV APAP 65 oritavancin semi 65 delivery polymer matrix 65 OMP #R# 65 MGCD# [001] 65 personalized dendritic cell 65 Phase III multicenter 65 Hematide ™ peginesatide 65 Nasdaq PPHM 65 oral antifungal 65 HDL Mimetic Peptide 65 enzastaurin 65 Enzyme Replacement Therapy 65 SUTENT ® 65 Fondaparinux 65 Shigamabs ® 65 PERLANE 65 Troxatyl TM 65 OMNARIS HFA 65 OMS#HP 65 Bone Graft 65 inhaled formulation 65 forodesine hydrochloride 65 IV acetaminophen 65 Optical Biopsy System 65 Celacade TM technology 65 visit www.targanta.com 65 Epidermal Growth Factor Receptor 65 somatropin Kuvan R 65 Adagen ® 65 inhibitor PPI 65 Inc Therapeutic Competitors 65 MKC# 65 5 Fluorouracil 65 Silenor ® 65 dihydrochloride Tablets 65 relapsed leukemia 65 Nasdaq DVAX 65 Ridaforolimus 65 octreotide implant 65 JAK2 inhibitor 65 Ixempra 65 sunitinib Sutent 65 Injectable Bone Graft 65 Nasulin ™ 65 BYETTA ® 65 BEMA TM Fentanyl 65 REPRONEX R menotropins 65 evaluating T DM1 65 cysteamine bitartrate 65 RhuDex TM 65 Aloxi ® 65 PRECISE trial 65 OvaRex ® MAb 65 CINOD 65 targeting CD# 65 EOquin 65 G#DT 65 www.allos.com 65 Adenoscan R 65 TM Aganocide